These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 6984124

  • 1. An appraisal of third complement component (C3) and breakdown product (C3d) in erythema nodosum leprosum (ENL).
    Saha K, Chakraborty AK, Sharma V, Sehgal VN.
    Lepr Rev; 1982 Dec; 53(4):253-60. PubMed ID: 6984124
    [No Abstract] [Full Text] [Related]

  • 2. Comprehensive evaluation of complement components in the course of type I (Lepra) and type II (ENL) reactions.
    Sehgal VN, Sharma V, Sharma VK.
    Int J Dermatol; 1989 Dec; 28(1):32-5. PubMed ID: 2783924
    [Abstract] [Full Text] [Related]

  • 3. Immune complexes in leprosy patients from an endemic and a nonendemic area and a longitudinal study of the relationship between complement breakdown products and the clinical activity of erythema nodosum leprosum.
    Valentijn RM, Faber WR, Lai A Fat RF, Chan Pin Jie JC, Daha MR, van Es LA.
    Clin Immunol Immunopathol; 1982 Feb; 22(2):194-202. PubMed ID: 6980747
    [No Abstract] [Full Text] [Related]

  • 4. Immune complexes and complement hypercatabolism in patients with leprosy.
    Bjorvatn B, Barnetson RS, Kronvall G, Zubler RH, Lambert PH.
    Clin Exp Immunol; 1976 Dec; 26(3):388-96. PubMed ID: 1009681
    [Abstract] [Full Text] [Related]

  • 5. The effect of anti-reactional drugs on complement components in the type II, erythema nodosum leprosum, reaction.
    Sehgal VN, Sharma V, Sharma VK.
    Br J Dermatol; 1988 Aug; 119(2):255-8. PubMed ID: 3166944
    [Abstract] [Full Text] [Related]

  • 6. Breakdown product of factor B as an index of complement activation in lepromatous leprosy and its relation with bacillary load.
    Saha K, Sharma V, Chakrabarty AK, Sehgal VN.
    Scand J Immunol; 1983 Jan; 17(1):37-43. PubMed ID: 6342123
    [Abstract] [Full Text] [Related]

  • 7. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
    Amorim FM, Nobre ML, Nascimento LS, Miranda AM, Monteiro GRG, Freire-Neto FP, Queiroz MDCP, Queiroz JW, Duthie MS, Costa MR, Reed SG, Johnson WD, Dupnik KM, Jeronimo SMB.
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
    [Abstract] [Full Text] [Related]

  • 8. Erythema nodosum leprosum (ENL) in histoid leprosy.
    Sehgal VN, Gautam RK, Srivastava G, Koranne RV, Beohar PC.
    Indian J Lepr; 1985 Jan; 57(2):346-9. PubMed ID: 4078360
    [Abstract] [Full Text] [Related]

  • 9. Serum immune complexes in erythema nodosum leprosum reactions of leprosy.
    Rao TD, Rao PR.
    Indian J Lepr; 1988 Apr; 60(2):189-95. PubMed ID: 3142953
    [Abstract] [Full Text] [Related]

  • 10. Complement determinations in the synovial fluid and serum of a patient with Erythema nodosum leprosum.
    Louie JS, Glovsky M.
    Int J Lepr Other Mycobact Dis; 1975 Apr; 43(3):252-5. PubMed ID: 1240873
    [Abstract] [Full Text] [Related]

  • 11. [Perioperative changes of complement (C1q, C3, C4) with cardiopulmonary bypass].
    Wang YT, Xu JX, Zhu YL.
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):86-8, 126-7. PubMed ID: 3264237
    [No Abstract] [Full Text] [Related]

  • 12. Numerical changes in T cell subsets (T gamma and T mu) in leprosy patients.
    Izumi S, Sugiyama K, Matsumoto Y, Nagai T.
    Microbiol Immunol; 1980 Apr; 24(8):733-40. PubMed ID: 6968392
    [Abstract] [Full Text] [Related]

  • 13. Suppressed natural killer cell activity during episodes of erythema nodosum leprosum in lepromatous leprosy.
    Humphres RC, Gelber RH, Krahenbuhl JL.
    Clin Exp Immunol; 1982 Sep; 49(3):500-8. PubMed ID: 7172493
    [Abstract] [Full Text] [Related]

  • 14. Immunoprofile of reactions in leprosy.
    Sehgal VN, Gautam RK, Sharma VK.
    Int J Dermatol; 1986 May; 25(4):240-4. PubMed ID: 3486843
    [Abstract] [Full Text] [Related]

  • 15. Complement activation and C1q binding activity in haemodialysis.
    Dodd NJ, Vergani D, Turney JH, Parsons V, Weston MJ.
    Proc Eur Dial Transplant Assoc; 1981 May; 18():300-4. PubMed ID: 6977138
    [No Abstract] [Full Text] [Related]

  • 16. Inhibition of de novo IgM antibody synthesis by thalidomide as a relevant mechanism of action in leprosy.
    Shannon EJ, Miranda RO, Morales MJ, Hastings RC.
    Scand J Immunol; 1981 May; 13(6):553-62. PubMed ID: 7031850
    [Abstract] [Full Text] [Related]

  • 17. Complement activation in the adult respiratory distress syndrome following cardiopulmonary bypass.
    Lew PD, Forster A, Perrin LH, Suter S, Neidhart P, Waldvogel F, Suter PM.
    Bull Eur Physiopathol Respir; 1985 May; 21(3):231-5. PubMed ID: 3873974
    [Abstract] [Full Text] [Related]

  • 18. Treatment of chronic erythema nodosum leprosum with cyclosporine A produces clinical and immunohistologic remission.
    Miller RA, Shen JY, Rea TH, Harnisch JP.
    Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):441-9. PubMed ID: 3309088
    [Abstract] [Full Text] [Related]

  • 19. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
    Job CK, Jacobson RR, Hastings RC.
    Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
    [Abstract] [Full Text] [Related]

  • 20. Complement activation in patients with amebic liver abscess.
    Muñoz LE, Salazar OG.
    J Hepatol; 1987 Aug; 5(1):30-6. PubMed ID: 2888804
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.